Bemis Co Inc (BMS) Falls 2.88% for January 25

Equities Staff |

One of the S&P 500’s big losers for Monday January 25 was Bemis Co Inc (BMS). The company’s stock fell 2.88% to $43.21 on volume of 671,571 shares.

The stock opened the day at 44.20 and traded between a low of $42.90 and a high of $44.20. The stock finished the day down $1.28 per share. Bemis Co Inc has an average daily volume of 677,039 and a total float of 95.97 million shares. The 50-day SMA for Bemis Co Inc is $45.24 and its 200-day SMA is $44.34. The high for the stock over the last 52 weeks is $49.44 and the low is $38.91.

Bemis Co Inc is a manufacturer of flexible packaging products and pressure sensitive materials, selling to customers throughout the United States, Canada, Mexico, South America, Europe, and Asia Pacific.

Bemis Co Inc is centered in Neenah, WI, and has 16,944 employees. Today’s trading day leaves the company with a market cap of $4.15 billion. The company has a P/S ratio of n/a, P/B ratio of 3.34, and a 21.8.

For a complete fundamental analysis analysis of Bemis Co Inc, check out Equities.com’s Stock Valuation Analysis report for BMS. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…

8tracks

Our mission is to be the best place for people who care about music to create and discover thoughtfully curated playlists. In essence, 8tracks is a platform for online mixtapes.